The cannabis company Dancann Pharma has today, January 7, submitted an application for voluntary delisting of the company's share from Spotlight Stock Market. This is stated in a press release.The background is that the company on October 6 announced that the company planned a voluntary delisting from Spotlight, which was approved at an extraordinary general meeting on October 21. Dancann Pharma will provide information on the last trading day for the share.